Join to View Full Profile
4860 Y StSuite 3500Sacramento, CA 95817
Phone+1 916-734-2823
Fax+1 916-734-8094
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Derya Tilki, MD is a urologist in Sacramento, California.
Education & Training
University of California, Davis, School of MedicineFellowship, Urologic Surgical Oncology, 2012 - 2014
University of HamburgClass of 2005
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 11 citationsNegative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer.Reha-Baris Incesu, Felix Preisser, Florian Nohe, Tobias Maurer, Markus Graefen
Prostate Cancer and Prostatic Diseases. 2025-12-01 - 3 citationsMolecular Correlates of Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: A Systematic Review.Tamás Fazekas, Maximilian Pallauf, Jakub Kufel, Marcin Miszczyk, Ichiro Tsuboi
European Urology Oncology. 2025-10-01 - 4 citationsSalvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis.Akihiro Matsukawa, Takafumi Yanagisawa, Tamas Fazekas, Marcin Miszczyk, Ichiro Tsuboi
Prostate Cancer and Prostatic Diseases. 2025-09-01
Authored Content
- Association of Age with Risk of Adverse Pathological Findings at Radical ProstatectomyApril 2020
- Association of Age with Risk of Adverse Pathological Findings at Radical ProstatectomyApril 2020
- 'Prognostic Value of Biochemical Recurrence Following Treatment with CurativeNovember 2018
Press Mentions
- Study Supports Salvage over Adjuvant RT After Prostate SurgeryNovember 2nd, 2020
The Lancet: Radiotherapy Following Prostate Cancer Surgery Can Safely Be Avoided for Many MenSeptember 28th, 2020
Setting the Standards: Examining Research Productivity Among Academic Urologists in the USA and Canada in 2019March 6th, 2020
